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The advent of percutaneous coronary intervention 
(PCI) transformed the treatment of obstructive coronary 
artery disease (CAD) by creating a less invasive 
revascularization option to coronary-artery bypass grafting 
(CABG).1 Although, randomized controlled clinical trials 
(RCTs) are the gold standard in medical research, there is 
not always the possibility to conduct properly designed 
RCTs. The gap between evidence from RCTs and clinical 
practice can be filled by epidemiological studies and 
properly designed registries.2 The results of the Hellenic 
Heart Registry on Percutaneous Coronary Interventions 
(HHR-PCI), a national registry of patients with stable 
angina or acute coronary syndromes who underwent PCI, 
were only recently published.3 The purpose of the current 
study is to report the experience of a newly formed 
Catheterization laboratory at a tertiary hospital of Athens 
and to compare its findings to those reported by the HHR-
PCI. 
Between 1/7/2013 and 31/5/2016, 438 patients who 
were admitted to the cardiology department of the “Elpis” 
General Hospital of Athens were submitted to PCI. The 
demographic characteristics of these patients are shown in 
Table 1. The majority of the population were males 
(80.1%), with a mean age of 63.6±11.8 years. A total of 
383 patients (87.4%) were of Greek origin, whereas 55 
(12.6%) were foreigners. Hypertension, hyperlipidemia, 
and smoking were all present in more than half of the 
patients (Table 1). Diabetes mellitus was also prevalent 
(26.9%). A total of 44.3% of the study participants 
underwent PCI for ST-elevation myocardial infarction 
(STEMI), while non-ST-elevation myocardial infarction 
(NSTEMI) was the indication for PCI in 27.9%, and 
unstable angina for 14.3% (Table 2a). Stable angina was 
the indication in just 13.2% of patients. The angiographic 
findings of our registry are reported in Table 2b. 
The demographic characteristics of our patients are 
similar to those of previous Greek studies,3-6 indicating that 
our study sample is representative of the Greek reality. 
There was a great predominance of males among patients 
who underwent PCI. All the conventional risk factors for 
CAD were especially prevalent among our patients. In 
addition, almost a quarter of them had a history of previous 
revascularization (either PCI or CABG), as in the HHR-
PCI, again signifying the need for better secondary 
prevention of CAD. Regarding the PCI indications, and in 
contrast to the HHR-PCI where there was a balance 
between acute coronary syndrome (ACS) and stable CAD, 
there was a predominance of ACS, with stable angina 
representing just a 13.2% of cases. This finding is 
especially important given the fact that there is still debate 
over the value of PCI in patients presenting with stable 
angina.7,8 Radial access was used in 93%, while femoral 
access was used in only 7% of cases. This proportion 
contrasts the one reported in the HHR-PCI and is really 
promising given the fact that the advantages of the radial 
route in terms of bleeding are unequivocal compared to the 
femoral route.9 The stent type most often used was drug-
eluting stents (DES) (about 95% of cases), being more than 
the one reported in HHR-PCI. There were 4 in-hospital 
deaths (0.9%). 
There are a number of limitations regarding our study, 
the first being the retrospective nature of data collection. 
Furthermore, except for in-hospital deaths there was not a 
uniform reporting of periprocedural complications and in-
hospital outcomes. Lastly, our study represents the 
experience of a single center. 
In conclusion, the population in our study mainly 
consisted of patients suffering an ACS and describes the 
experience of our center in treating these acutely ill 
patients. There is an urgent need of a national registry for 
PCI that will help our country to conform to international 
standards, especially during the financial crisis period that 
funds allocated to the health sector are decreasing almost 
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every year and abiding to these standards is of outmost 
importance. 
 
Table 1. Characteristics of study population (438 patients).  
  Values*  
Patients  438 (100)  
Males  351 (80.1)  
Females  87 (19.9)  
Greeks  383 (87.4)  
Foreigners  55 (12.6)  
Age (years)  63.6±11.8  
HTN  273 (62.3)  
Hyperlipidemia  225 (51.4)  
DM  118 (26.9)  
Smoking  234 (53.4)  
History of CAD  78 (17.8)  
Prior PCI  75 (17.1)  
Prior CABG  20 (4.6)   
*Values are mean ± SD for continuous variables, and n (%) for 
categorical variables.  
Hypertension (HTN) was defined as history of hypertension or 
blood pressure ≥140/90 mmHg. Hyperlipidemia was defined as 
history of hyperlipidemia, or LDL ≥160 mg/dl, or TC ≥240 
mg/dl. Diabetes mellitus (DM) was defined as history of 
diabetes, or FBS ≥126 mg/dl, or HbA1c ≥6.5%. 
CAD: coronary artery disease; PCI: percutaneous coronary 
intervention; CABG: coronary artery bypass grafting; FBS = 
fasting blood sugar; TC = total cholesterol   
Table 2a. PCI indication (433 patients). 
 Values* 
STEMI 192 (44.3) 
NSTEMI 121 (27.9) 
Unstable angina 62 (14.3) 
Stable CAD 57 (13.2) 
* Values are mean ± SD for continuous variables, and n (%) for 
categorical variables.  
CAD: coronary artery disease; NSTEMI; non ST-segment 
elevation myocardial infarction; PCI: percutaneous coronary 
intervention; STEMI; ST-segment elevation myocardial 
infarction. There were missing data for 5 patients.   
Table 2b. Angiographic findings (438 patients). 
 Values* 
1 VD 160 (36.5) 
2 VD 149 (34.0) 
3 VD 129 (29.5) 
Treated LM 25 (5.7)  
Treated LAD 332 (75.8)  
Treated LCX 231 (52.7)  
Treated RCA 284 (64.8)  
* Values are mean ± SD for continuous variables, and n (%) for 
categorical variables.  
LAD = left anterior descending artery; LCX = left circumflex 
artery; LM = left main; RCA: right coronary artery; VD = vessel 
disease.  
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